Skip to content
Use caution Medical device recall · FDA · Published December 12, 2023

Steris Dual Articulating Headrest Recall: Risk of Patient Injury During Procedures

Steris recalls certain Dual Articulating Headrest models (P/N P141210805, REF BF754) due to potential failure to lock during patient procedures, risking injury or delays.

🇺🇸 FDA recall #Z-0983-2024Medical deviceSteris ›
Take action

Contact the company

Recalling firmSteris Corporation5960 Heisley Rd · Mentor, OH 44060-1834
✎ GovInfoNow plain-language explainer

Steris is recalling specific Dual Articulating Headrest models that may not stay securely in place or lock during patient procedures, which could cause patient injury or procedural delays. This recall affects medical devices used in healthcare settings. Read more at govinfonow.com/recall/56569-steris-dual-articulating-headrest-recall-risk-of-patient-injury-during.

Source Summary by GovInfoNow · govinfonow.com/recall/56569-steris-dual-articulating-headrest-recall-risk-of-patient-injury-during · Updated August 18, 2026 · FDA enforcement record: FDA #Z-0983-2024

Cite this page

“Steris Dual Articulating Headrest Recall: Risk of Patient Injury During Procedures.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/56569-steris-dual-articulating-headrest-recall-risk-of-patient-injury-during. Based on FDA recall #Z-0983-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0983-2024%22&limit=1).

The FDA announced on 2023-12-12 that Steris Corporation is recalling the Dual Articulating Headrest, Pad Ret P/N P141210805, REF BF754. The device may fail to lock into position during a patient procedure, which could result in injury or procedural delay.

How to tell if you have it

  • Brand: Steris
  • Product: Dual Articulating Headrest, Pad Ret P/N P141210805, REF BF754
  • UDI-DI: 00724995197643
  • Date of manufacture: 2023-08-14 thru 2023-10-26

The hazard

The dual-articulating head rest may not stay in place or may fail to lock into position during a patient procedure. This failure could result in an injury to the patient or a procedural delay.

Context

GovInfoNow's records show Steris Corporation has 29 other recalls on record since 2017-06-15. Other recent recalls include the Steris ALYON Surgical Lighting System Recall for buttons that may detach and paint delamination (2026-05-15), and the Steris AMSCO 7052HP Washer/Disinfector Recall for electrical arcing risk (2025-11-19). Other recent recalls of similar products include the IMRIS ORT200 Operating Room Table Recall for risk of patient injury from mechanical failure and the IMRIS ORT300 Operating Room Table Recall for risk of patient injury from unintended movement (both 2026-08-06), as well as the Merit Medical Vascular Tray Recall where the handle may detach during procedure (2025-12-04).

How to tell if you have this one

Check for the product number P141210805 and reference number BF754 on the headrest. The recall covers units manufactured from August 14 to October 26, 2023.

  • Brand
    Steris
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide - US Nationwide distribution in the states of AZ, CA, FL, IL, IN, IA, KS, LA, MN, MS, NV, NJ, OH, OK, OR, PA, TN, TX, UT, WA, WI & Puerto Rico, and the countries of Australia, Canada, Mexico & New Zealand.
Recall numberProduct, codes & lotsQuantity
Z-0983-2024Dual Articulating Headrest, Pad Ret P/N P141210805, REF BF754; UDI-DI: 00724995197643, date of manufacture 2023-08-14 thru 2023-10-26.2
Z-0984-2024Dual Articulating Headrest, Velcro P/N P141210813, REF BF753; UDI-DI: 00724995195885, date of manufacture 2023-08-14 thru 2023-10-26.80
Based on the official FDA remedy

What to do — step by step

  1. Check Headrest Model

    Look for the product number P141210805 and reference number BF754 on the headrest.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 21 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - US Nationwide distribution in the states of AZ, CA, FL, IL, IN, IA, KS, LA, MN, MS, NV, NJ, OH, OK, OR, PA, TN, TX, UT, WA, WI & Puerto Rico, and the countries of Australia, Canada, Mexico & New Zealand.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Arizona, California, Florida, Illinois, Indiana, Iowa, Kansas, Louisiana, Minnesota, Mississippi, Nevada, New Jersey, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Tennessee, Texas, Utah, Washington, Wisconsin.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Dec 12, 202312. FDA classified it Class II: Feb 5, 202423. Published in FDA’s Enforcement Report: Feb 14, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0983-2024 (December 12, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0983-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA